On Invalid Date, Cocrystal Pharma (NASDAQ: COCP) reported Q4 2023 earnings per share (EPS) of -$0.44, up 18.52% year over year. Total Cocrystal Pharma earnings for the quarter were -$4.46 million. In the same quarter last year, Cocrystal Pharma's earnings per share (EPS) was -$0.54.
As of Q2 2024, Cocrystal Pharma's earnings has grown year over year. Cocrystal Pharma's earnings in the past year totalled -$17.98 million.
What is COCP's earnings date?
Cocrystal Pharma's earnings date is Invalid Date. Add COCP to your watchlist to be reminded of COCP's next earnings announcement.
What was COCP's revenue last quarter?
On Invalid Date, Cocrystal Pharma (NASDAQ: COCP) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Cocrystal Pharma's revenue was $0.00.
What was COCP's revenue growth in the past year?
As of Q2 2024, Cocrystal Pharma's revenue has grown null year over year. Cocrystal Pharma's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.